Hemispherx Biopharma Reports Article by Senior Authors From Italian Ministry of Health and Related Agencies Suggesting Broad Applicability of Ampligen(R) to Multiple Sclerosis
September 23, 2015 08:30 ET
|
AIM ImmunoTech Inc.
PHILADELPHIA, Sept. 23, 2015 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE MKT:HEB) announced today a new peer reviewed article, with senior authors from the Italian Ministry of Health and other...
The International Journal of Cancer Publishes Studies on the Anti-Cancer Activity of Generex Biotechnology's Immunotherapeutic Vaccine
July 31, 2007 08:00 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., July 31, 2007 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) announced today publication in the peer-reviewed International Journal of Cancer (published online...